chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician via company representative through an online article referring to unspecified number of patients of unknown age and gender. The patients' concurrent conditions, medical histories and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) (lot #, expiration date, dose and route were unknown) for prophylaxis. On unknown dates, the patients who had a known vaccination status caught the mumps. It reported that although getting a vaccine may not prevent illness, it probably helped those who do get sick avoid serious complications. During the pre-vaccine era, between 20% and 50% of boys would develop orchitis: swollen testicles, of those, a third would develop infertility. Only 17 boys were seen to develop orchitis in this outbreak, much fewer than in the pre-vaccination era. It was also reported that only six hospitalizations (reason unspecified) were seen and the vaccine was definitely making the illness milder than it would otherwise be. The outcome of the events was unknown. The reporter did not assess the causality. Additional information has been requested.
Nausea x1 day, upset stomach x1 day, fatigue 6 days so far...ongoing.
This case was reported by a healthcare professional and described the occurrence of an unspecified adverse event in a subject of unspecified age and gender who was vaccinated with (INFANRIX, GlaxoSmithKline). On an unspecified date the subject received 4th dose of INFANRIX (unknown). At an unspecified time after vaccination with INFANRIX, the subject experienced an unspecified adverse event. The reporter believed that there might be a quality assurance problem that caused the adverse event. This was considered to be a product complaint. At the time of reporting the outcome of the events was unspecified. The healthcare professional considered the events were probably related to vaccination with INFNARIX. The representative was not sure it the INFANRIX was in prefilled syringes or vials. Follow-up information from Quality Assurance was received on 23 June 2009. The INFANRIX vaccine lot AC14B088AA met the requirements of our specifications and batch was suitable for vaccination purposes. Linked cases include A0772416A and A0772420A.
About 8 hours after injection,  minor chills started.  One hour later, chills became severe. About 13 hours after injection, I felt like I had a full blown case of the flu...fever, chills, sweats, light heaviness, body aches and general nausea.  Sleep was irregular.  Next day, symptoms subsided, but still had body aches and fatigue, and I called in sick for work.
congestion, headache, tired, coughing, O2 between 87 and 92 after fixing something to drink and walking across room
I got one 15 years ago, then I got the flu, haven't had the shot or the flu since then; Initial information received on 17-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-HCP.  This case involves an unknown age and unknown gender patient who said that I got one 15 years ago, then I got the flu, haven't had the shot or the flu since then after receiving INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Influenza vaccine by unknown manufacturer (strength, dose, formulation, frequency, lot number and expiry date: not reported) via unknown route in unknown administration site for Prophylactic vaccination (Immunisation).  On an unknown date the patient had a non-serious event, "I got one 15 years ago, then I got the flu, haven't had the shot or the flu since then (influenza)" (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported, "Description: Not today flu shot, I got one 15 years ago, then I got the flu, haven't had the shot or the flu since then. Since this is a public post we are assuming the consumer is referring to the Sanofi flu vaccine."  No lab data was reported.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown.
Body ache; Chills; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Body ache), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, MYALGIA (Body ache), CHILLS (Chills), PYREXIA (Fever) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant product information was not provided. Treatment information was not provided.   This case was linked to MOD-2021-184845, MOD-2021-184845 (Patient Link).
Day 1 - fever, malaise, chills, shivering, arm pain Day 2 - arm pain, swelling and redness 2 inches wide by 1 1/2 inches high  about 2 inches below injection site , LOWER GI problems frequent soft movements and severe gas. (Cramps and smell), headache
Initial report was received 02 May 2011 from the above referenced scientific literature report which described ongoing research involving eight milk allergic children who received either Tdap or DTaP vaccinations and within one hour after vaccination, experienced anaphylactic reactions. These events occurred between September 2007 and March 2010 (captured in case number 2011-01614). According to the literature report, during that same period, the national Vaccine Adverse Event Reporting System (VAERS) listed only 42 anaphylactic reactions for patients under 17 years old to the Tdap and DTaP vaccines (manufacturers unknown, lot numbers not reported). This information was noted in the literature report as being obtained from a poster which had been presented by a physician at the Academy of Allergy, Asthma and Immunology. Outcomes were not reported. No additional information was provided at the time of the report. The reporter for this case is the same as for case numbers 2011-01614 and 2011-01616. Documents held by sender: none.
Heart rate gone upto 112; Fatigue; Myalgia in extremities; Low grade fever; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of FATIGUE (Fatigue), MYALGIA (Myalgia in extremities), PYREXIA (Low grade fever) and HEART RATE INCREASED (Heart rate gone upto 112) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included AFib.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced FATIGUE (Fatigue), MYALGIA (Myalgia in extremities) and PYREXIA (Low grade fever). On an unknown date, the patient experienced HEART RATE INCREASED (Heart rate gone upto 112). At the time of the report, FATIGUE (Fatigue), MYALGIA (Myalgia in extremities), PYREXIA (Low grade fever) and HEART RATE INCREASED (Heart rate gone upto 112) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    No relevant concomitant medications were reported.    No treatment information was provided.
Pain at injection site, upon injection. Pain still present as of 11-14-2008. Patient saw Dr, had x-ray done. Shows arthritis in shoulder joint.
Information has been received from a Nurse Practitioner (N.P.) concerning a female patient in her early 20's who on an unspecified date was vaccinated with her first dose of Gardasil. Five minutes after receiving the injection, the painted fainted. She was given fruit juice. Her outcome was unknown. Additional information has been requested.
Pt recvd vax 14MAY93 & w/in hrs had a fever of 105.5, shaking chills & turning blue (even nailbeds); MD visit 18MAY still febrile; rx w/APAP & Advil;
This spontaneous report was received from a nurse (licensed vocational nurse) refers to a 52 year old female patient. The patient's pertinent medical history included hypothyroidism and dyslipidaemia. Patient was allergic to codeine (manufacturer unknown). On 07-SEP-2016 the patient was vaccinated with PNEUMOVAX 23 (lot # L029306 and expiration date as 26-MAR-2017) 0.5 ml, intramuscular injection. Concomitant therapies included ZETIA and levothyroxine sodium (manufacturer unknown). On 07-SEP-2016 (reported as in the evening) the patient experienced severe body ache and severe right arm pain, the patient also vomited once and had muscle weakness needing assistance to get up and walk (abasia) (medically significant). It was also reported that the patient took Ibuprofen (manufacturer unknown) and it helped with the body ache but did not help with the right arm pain. On 07-SEP-2016 the patient also felt cold but her relatives stated that her skin felt very hot. On an unknown date in September 2016 the patient underwent unspecified blood work results were not specified. The patient sought medical attention and contacted her doctor. There was no product quality complaint reported. The outcome of the adverse events  was reported as recovering. The causality assessment was not provided by the reporter. Upon internal review the event abasia was considered to be medically significant. Additional information has been requested.
pt recvd vax 18OCT95 & devel gen rash 28OCT; swelling of hand; seen @ clinic dx polyarticular arthritis rt & lt hand bilat w/lab;
Headache was a 6 until end of day, arm was tender for one week after injection with no bruising.
2 days after receiving vaccine patient developed hives on trunk, face, arms and legs and swelling of lips. Right arm felt heavy 1 day after receiving vaccine.
Pt described getting "very sick" - so bad he had to go to the doctor. Said he got a very sore throat and congestion. Sx sounded more like a cold than the flu. Had "itching" around and above injection site - he came in 10/4/11 and showed us the rash. Where the injection was, there was still a small red mark. Looked like scabs above the injection site - like he had scratched hard enough to cause bleeding. Asked when the itching started and he said "I don't know".
his arm hurt after the second dose; This is a spontaneous report received from a Pfizer sponsored program. A contactable consumer (patient) reported that a male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on 19Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation  .  The patient previously took the first dose bnt162b2 on 21Jan2021 for covid-19 immunization. The patient medical history was not reported.     The patient's concomitant medications were not reported.  The patient experienced his arm hurt after the second dose  on an unspecified date with outcome of unknown.    No follow-up attempts are possible. No further information is expected. Information about lot/batch number cannot be obtained.
Large knot and itching at injection site with red spot the size of an eraser. There is also muscle pain with movment of arm.
Muscle Knots and spasms on left side of upper body including scapula shoulder base of skull left arm; Muscle Knots and spasms on left side of upper body including scapula shoulder base of skull left arm; Numbness on left side of face and tongue; Numbness on left side of face and tongue; Headaches; Dizziness; Flushing with ears burning; Brain fog; Nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Jan2023 at 15:00 as dose 4 (booster), single (Lot number: GJ6796) at the age of 65 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Necrological Lyme Disease" (unspecified if ongoing), notes: Recovered from Neurological Lyme Disease. Concomitant medication(s) included: MAGNESIUM CITRATE; D3. Vaccination history included: Covid-19 vaccine (DOSE 1, Manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (DOSE 2, Manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (DOSE 3, Manufacturer unknown), for COVID-19 immunization. The following information was reported: FEELING ABNORMAL (non-serious) with onset 11Jan2023 at 15:00, outcome "not recovered", described as "Brain fog"; DIZZINESS (non-serious) with onset 11Jan2023 at 15:00, outcome "not recovered"; EAR DISCOMFORT (non-serious) with onset 11Jan2023 at 15:00, outcome "not recovered", described as "Flushing with ears burning"; HEADACHE (non-serious) with onset 11Jan2023 at 15:00, outcome "not recovered", described as "Headaches"; MUSCLE SPASMS (non-serious) with onset 11Jan2023 at 15:00, outcome "not recovered", MUSCULOSKELETAL PAIN (non-serious) with onset 11Jan2023 at 15:00, outcome "not recovered" and all described as "Muscle Knots and spasms on left side of upper body including scapula shoulder base of skull left arm"; NAUSEA (non-serious) with onset 11Jan2023 at 15:00, outcome "not recovered"; HYPOAESTHESIA (non-serious), HYPOAESTHESIA ORAL (non-serious) all with onset 11Jan2023 at 15:00, outcome "not recovered" and all described as "Numbness on left side of face and tongue". The events "muscle knots and spasms on left side of upper body including scapula shoulder base of skull left arm", "numbness on left side of face and tongue", "headaches", "dizziness", "flushing with ears burning", "brain fog" and "nausea" required physician office visit. Therapeutic measures were not taken as a result of muscle spasms, musculoskeletal pain, hypoaesthesia, hypoaesthesia oral, headache, dizziness, ear discomfort, feeling abnormal, nausea.  Additional information: No other vaccine in four weeks. Other medication in two weeks included  Magnesium citrate 200 mg BID (two times in a day). D3 2000 IU. Reported Muscle Knots and spasms on left side of upper body including scapula shoulder base of skull left arm. Numbness on left side of face and tongue. Headaches. Dizziness. Flushing with ears burning. Brain fog. Nausea. No COVID prior vaccination. Not tested for COVID post vaccination.
2 days after the administration of the vaccine, pt developed gradual left patellar tendon pain followed by diffuse muscle aches, fever, and malaise.  This then subsided and developed into an oligoarthropathy involving the left wrist and R ankle.  He has remained on NSAID treatment and rest for approx 9 days now.
Patient was given a dose of Tdap (Adacel) previously on 8-26-2022. Patient was administered a second dose on 8-29-2022.  MA who administered the vaccine reported the incident to the nurse manager immediately after adminstering. The nurse manager notified the physician and the office administrator. No adverse outcomes reported per the physician who followed up with patient.
I woke up in the night with a raging urinary tract infection.  Pain level was 7 or 8 out of 10.  The shot I got was a booster.
The 2nd day after the shingles shot, the injection area started to become very itchy, red and hot, not pain. Pt is allergic to thimerosal, flu shot spot is fine.
Low grade fever; chills; body aches; fatigue; This is a spontaneous report from a contactable consumer reporting for herself. A 50-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, solution for injection, Lot number was not reported), via an unspecified route of administration, administered in left arm on 06Feb2021 at 11:45 (Age at vaccination: 50 years) as single dose for covid-19 immunization. Patient did not receive other vaccine in 4 weeks. Patient did not have COVID prior vaccination. Patient did not test COVID post vaccination. Patient had supra drug allergy. Patient concomitant medications were not reported. The patient experienced low grade fever, chills, body aches and fatigue on 07Feb2021 at 04:45. Treatment was not received for the events. The outcome of the events was recovering.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
During the end of January. I was having sore throat and mostly coughing and runny nose.  The symptoms lasted about a week before I decided to contact my PCP. I did not do any testing to see if I had COVID-19. I just called my doctor and asked him to call in a Z-Pack. The symptoms lasted even longer after the medicine.  Later in the third week in February I started feeling a bit better. I still don't know what I had.
This spontaneous report as received from a pharmacist refers to patients of unknown age and gender. On an unknown date, patients were vaccinated with improperly stored VARIVAX (Merck) (dose, route, lot # and expired date were not reported). Concomitant therapy was not reported. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
heart palpitations; This spontaneous case was reported by a pharmacist and describes the occurrence of PALPITATIONS (heart palpitations) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced PALPITATIONS (heart palpitations). At the time of the report, PALPITATIONS (heart palpitations) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   The patient still has heart palpitations, but they are occurring less frequently.   No treatment information was provided.
Possible administration of expired vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Possible administration of expired vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Possible administration of expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Possible administration of expired vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.   Treatment information was not provided.
rash; rough rash; This case was reported by a consumer via call center representative and described the occurrence of red rash in a 53-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th October 2019, the patient received the 1st dose of Shingrix (intramuscular). In October 2019, couple of days after receiving Shingrix, the patient experienced red rash and skin rough. On an unknown date, the outcome of the red rash and skin rough were unknown.   It was unknown if the reporter considered the red rash and skin rough to be related to Shingrix.  Additional details were provided as follows: The patient experienced a rash on the back of his left calf muscle, 3 spots that are red and rough about the size of a dime or smaller.  The reporter consented to follow up.
On 10/12/2021 the PA-C from facility ordered a covid 19 antibodies blood test. The results came back the morning of 8/14/21.  It showed that I had zero antibodies.
15 x 15cm red warm browny area mostly under inj. site left deltoid. Advised to use ice pack and motrin prn
I had my vaccination on 11/11/2022. On 02/05/2023 I had pounding headache and bad cold symptoms to include wheezing. I tested COVID-19 positive on 02/05/2023. I contacted my physician who prescribed me PAXLOVID. I previously had COVID-19 in 05/2022. I do feel better on 04/06/2023.
Received Covid booster on Monday; fatigue; sore arm; This is a spontaneous report received from a contactable reporter(s) (Pharmacist). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (COMIRNATY), administration date 06Dec2021 (Batch/Lot number: unknown) as dose 3 (booster) single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 Immunization; Bnt162b2 (DOSE 2, SINGLE), for Covid-19 Immunization, reaction(s): "fatigue", "body ache".  The following information was reported: IMMUNISATION (non-serious) with onset 06Dec2021, outcome "unknown", described as "Received Covid booster on Monday"; FATIGUE (non-serious) with onset Dec2021, outcome "unknown", described as "fatigue"; PAIN IN EXTREMITY (non-serious) with onset Dec2021, outcome "unknown", described as "sore arm".  Additional information: Received Covid booster on Monday (06Dec2021) and experienced fatigue and sore arm on Monday/Tuesday (06Dec2021 or 07Dec2021) and event took place after use of product.  The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021333169 same patient, different dose/event
Vaccination: 1. Pfizer EL9-263  01/21/21 2. Pfizer EM9809 02/10/21
SORE ARM; FATIGUE SEEM TO BE WORSENING; INCREASED BODY TEMP ABOUT 98; This spontaneous report received from a patient concerned a 73 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included history of chronic fatigue, and shellfish allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021, vaccinated at right deltoid for prophylactic vaccination. No concomitant medications were reported. On 09-MAR-2021, the subject experienced increased body temp about 98. Laboratory data included: Body temperature increased (NR: not provided) about 98. On 17-MAR-2021, the subject experienced sore arm. On 17-MAR-2021, the subject experienced fatigue seem to be worsening. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm on 21-MAR-2021, and increased body temp about 98 on 10-MAR-2021, and had not recovered from fatigue seem to be worsening. This report was non-serious.